Malaria drug fails to prevent COVID-19 in a rigorous study

A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease.

Understanding the Impact Of COVID-19 On Essential Medicine Supply Chains, Center For Global Development

Malaria Drug Hydroxychloroquine Provides No Covid-19 Protection - Bloomberg

Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies - Cytotherapy

India likely to welcome Trump's use of Malaria drug

Global study to test malaria drug to protect health workers from COVID-19 – Washington University School of Medicine in St. Louis

IJMS, Free Full-Text

Chloroquine for COVID-19: rationale, facts, hopes, Critical Care

Malaria drug hydroxychloroquine fails to prevent COVID-19 in a rigorous study - ABC7 San Francisco

Searching for an effective Covid-19 treatment: promise and peril - STAT

Malaria drug touted by Trump fails to prevent COVID-19 in high profile study

The Strange and Twisted Tale of Hydroxychloroquine

Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis

Clinical trials planned to put hydroxychloroquine to the test for COVID-19

Trump's claim that malaria drug can treat coronavirus gives hope, but little evidence it will work